Quantamental Technologies LLC Vaxart, Inc. Transaction History

Quantamental Technologies LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$5.77 - $7.96 $161,133 - $222,290	-27,926 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$6.67 - $9.8 $186,266 - $273,674	27,926 New	27,926 $222,000
Q1 2019 Apr 29, 2019	SELL	$1.5 - $2.34 $3,486 - $5,438	-2,324 Closed	0 $0
Q4 2018 Jan 28, 2019	BUY	$1.88 - $5.25 $4,369 - $12,201	2,324 New	2,324 $4,000

106

24.9M

77K

45.8K

Ticker VXRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,506,000
Market Cap $82.2M
Description
Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1...

Get notified when there are updates to the investment portfolio of Quantamental Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Quantamental Technologies LLC with notifications on news.